GSK bosses reveal vision for gateway of Ulverston factory
Last updated at 17:11, Wednesday, 11 June 2014
GSK bosses have revealed their vision for the gateway of the company's factory in Ulverston.
Barrow based Craig and Meyer Architects Ltd has been appointed to progress the designs for GSK’s latest development at the site, for which a planning application was submitted earlier this month.
The proposed single storey building will complete GSK’s programme to provide improved car parking, access, approach and vehicle marshalling facilities for the Ulverston factory.
With a total footprint of 208 square metres, the use of traditional materials and natural stonework found in the South Lakeland area is at the forefront of the design concept for the security gatehouse and reception facility.
Designed to ensure clear visibility from the buildings into the car park, a semi-circular security office and observation window will offer a panoramic view over a new delivery, drop-off and pick up area for light good vehicles, a heavy good vehicles holding and turning area and parking spaces for HGVs.
Vehicle access will be separate from the access for pedestrians, whilst both are monitored and controlled by staff within the security gatehouse.
Pat McIver, the GSK Site Biopharm Lead, said: “The new gatehouse development will provide a modern, purpose-designed, highly functional security facility with more visible ‘gateposts’ for controlled access and egress.
“It will combine a clean and efficient aesthetic too, with smart stone cladding and large glazed panels on windows and doors to create a crisp and clean appearance. It’s an appropriate addition for a first class production facility.
“The appointment of Craig and Meyer Architects underlines our continuing commitment to utilising local, professional services expertise whenever we can.”
Craig and Meyer Architects Director Steve Meyer adds: “We’re pleased to be involved with the development of the new gatehouse and access project at GSK Ulverston.
“We’re working directly with ARUP to supply architectural design services in conjunction with their civil and building services engineering design.
“We have always promoted the use of local businesses whenever possible, and we’re grateful to GSK for recognising the contribution which local companies can make, and for the opportunity to be involved with the significant new investment being made at Ulverston. This will undoubtedly be a substantial boost for the local economy.”
Ancillary facilities within the new gatehouse development are set to include a training room, staff meeting room, service accommodation, visitor toilets, shower facilities for cyclists and delivery drivers, a covered cycle park and security turnstiles. Pedestrian entrances will be access compliant for both ambulant, disabled and wheelchair users.
First published at 12:01, Wednesday, 11 June 2014
Published by http://www.nwemail.co.uk
Have your say
No amount of posh and polish can masque the behind-the-scenes activity of the vivisection and animal testing that goes on at GSK.
It would be nice if GSK had invested this money into already-existent alternative testing methods that replaced laboratory animals. Unfortunately, since much money comes with using animals for experimentation, the vast majority of pharmaceutical companies still use animals for research and testing. In the 21st Century, it's time to move forward to more humane methods that don't involve the use of animals to test drugs and chemicals.